Clin2
NCT07296328Possibly a fitNot yet recruiting

Psilocybin treatment for stuttering

Stuttering

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether a single dose of psilocybin (a psychedelic medicine) can improve speech fluency and reduce struggle in adults who stutter. It looks at brain activity before and after the dose to see how psilocybin works on the brain's speech areas.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
25 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You must be between 18 and 50 years old.
  • You must have a confirmed stuttering diagnosis from a specialist.
  • You must be able to attend all study visits and therapy sessions.
  • You must agree to avoid non-prescribed drugs and alcohol before study days.
  • You must be willing to use birth control during the study (if you can become pregnant).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07222163Recruiting
Stuttering study with brain stimulation

This study tests whether a safe, non-invasive brain stimulation technique called tDCS can help reduce stuttering. It involves attending several sessions where you receive either active stimulation or a placebo, while you speak or do tasks.

New York, New York
NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut
NCT06349083Recruiting· Phase 2
Psilocybin-assisted treatment for alcohol use disorder

This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.

New York, New York
NCT07053917Recruiting· Phase 1
Psilocybin therapy for stroke recovery

This trial tests whether a medicine called psilocybin (a psychedelic compound) can help people who had a stroke more than a year ago. It aims to see if the therapy can improve healing and flexibility in the brain.

Baltimore, Maryland
NCT05995769Recruiting· Phase 2
Psilocybin therapy with talk therapy for alcohol problems

This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.

Calgary, Alberta
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin effects on memory and brain function

This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.

Austin, Texas

Hear when a new Stuttering trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.